Wednesday 14 February 2024 | 18:05 Relief on horizon for Cyprus’ thalassemia sufferers The European Commission has greenlighted the use of Casgevy gene-therapy to treat beta thalassemia and sickle cell disease, in a move heralded as a “milestone” for the fight against human ... By Andria Kades
